{"schema_version":"secwatch.filing_event.v1","accession":"0001040130-24-000043","form_type":"8-K","ticker":"PETS","cik":"0001040130","company_name":"PETMED EXPRESS INC","filed_at":"2024-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.987901+00:00","generated_at":"2026-06-01T04:58:27.765711+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"PetMed Express Q4 net loss widens to $5.0M; FY net loss $7.5M vs prior year profit","bullets":["Q4 net sales $66.5M (+6.6% YoY) driven by PetCareRx acquisition; legacy PetMeds sales declined.","Q4 net loss $5.0M ($0.25 diluted EPS) vs loss $0.2M ($0.01) in prior year quarter.","FY 2024 net loss $7.5M ($0.37 diluted EPS) vs net income $5.1M ($0.25) in FY 2023.","Adjusted EBITDA Q4 $0.5M (from $3.6M); FY $8.2M (from $19.8M) as G&A and marketing rose.","CEO cites challenging macro environment and new Order Management System slowdown in Q4."],"urls":{"canonical":"https://secwatch.observer/filing/0001040130-24-000043","json":"https://secwatch.observer/filing/0001040130-24-000043.json","markdown":"https://secwatch.observer/filing/0001040130-24-000043.md","text":"https://secwatch.observer/filing/0001040130-24-000043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1040130/000104013024000043/0001040130-24-000043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1040130/000104013024000043/pets-20240611.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:58:27.765711+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}